A decision-ready blueprint
A governed strategy and digital architecture designed around the commercial realities of academic technology transfer offices and research centers.
Scientific, commercial, and digital architecture, with specialist expertise assembled where the engagement requires it.
Governed architecture model
A principal-led model that connects source context, configured systems, review ownership, and practical delivery for academic ttos & research centers.
Technology transfer and translational research teams work across research evidence, intellectual property, development milestones, partner discovery, and commercialisation decisions. The challenge is to create a connected view of those elements while respecting the distinct roles of researchers, technology-transfer professionals, external advisors, and institutional governance.
Lonrú Consulting designs architecture that supports that work. We help define how evidence is assembled, reviewed, shared, and translated into a practical pathway for opportunity assessment, partner engagement, and commercialisation.
We define the research, IP, translational, market, and partner sources relevant to the question, together with source ownership, permissions, and the boundary between internal and external material.
Where useful, configured systems can help structure evidence, prepare opportunity material, or support a repeatable analysis within the agreed context. They do not replace institutional or scientific approval.
Lonrú provides principal-led architecture and review governance. Research leads, technology-transfer professionals, institutional decision-makers, and client-selected specialists can provide review or final approval according to the engagement.
Approved outputs can be delivered through an opportunity-assessment view, translational tracker, partner-facing workspace, portfolio interface, or decision briefing environment.
Relate research, IP, translational milestones, market context, and partner questions without losing source provenance or institutional review requirements.
Define what can be prepared for a potential partner, what remains internal, and which approvals are required before information moves outside the institution.
Design a tracker or decision surface that shows the current evidence, open questions, dependencies, and next accountable action for a selected opportunity.
Create the architecture behind a reusable process for opportunity assessment, partner discovery, licensing preparation, or portfolio discussion.
Technology transfer architecture must work with the institution's own decision rights, research culture, and IP responsibilities. We make those boundaries explicit before introducing a new interface, portal, or analytical capability.
The result is a practical blueprint that can help the organisation prioritise the first useful digital workstream without treating commercialisation as a purely technical exercise.
Relevant experience
Preclinical to IND
Created interactive Preclinical-to-IND decision-tree frameworks and risk-mitigation reports to help advanced-therapy enabling-technology companies align product capabilities with FDA IND validation requirements and reduce preclinical translation delays.
Audit-ready
Formulated Technical Dossier Authoring frameworks that automate ingestion and structure of preclinical data pipelines for FDA IND and BLA submissions, producing organized, audit-ready regulatory dossiers.
Practical questions
Next step
Bring the decision, workflow, or delivery constraint that needs a clearer operating path.
Request a focused briefing